C3i was proud to participate in Advanced Therapies Week, which took place in Dallas from January 20 to 23, 2025.

As a key event in the biotech industry, ATW 2025 gathered 2,500 attendees, 100 investors, 600 biotech companies, and 180 exhibitors at the Kay Bailey Hutchinson Convention Center. With six content tracks and 250 expert speakers, the event fostered innovation, regulatory discussions, and strategic collaborations to advance the future of cell and gene therapies.

This conference, organized by Phacilitate, provided a valuable opportunity to connect with industry leaders, share knowledge, and stay at the forefront of what we do best: bringing life-saving cell therapies from the laboratory to the clinic.